Canaccord Genuity Starts Black Diamond Therapeutics (BDTX) at Buy
Tweet
Share
E-mailGet Alerts BDTX Hot Sheet
Price: $2.02 --0%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity analyst Arlinda Lee initiates coverage on Black Diamond Therapeutics (NASDAQ: BDTX) with a Buy rating and a price target of $50.00.
For an analyst ratings summary and ratings history on Black Diamond Therapeutics click here. For more ratings news on Black Diamond Therapeutics click here.
Shares of Black Diamond Therapeutics closed at $37.92 yesterday.
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform
- Alliance Global Partners Starts Momentus (MNTS) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
